(PharmaNewsWire.Com, December 22, 2017 ) The North America Autoimmune Diagnostics Market was worth $5.48 billion in 2016 and estimated to reach $ 6.48 billion by the end of 2021 with a growing potential of 3.40%. The term “autoimmune disease” refers to a different type of illnesses that involve almost every human organ system. It includes diseases of the nervous, endocrine systems, gastrointestinal and other connective tissues, blood, eyes and blood vessels.
NIH expected that up to 23.5 million Americans have an Auto immune disorders. In comparison, heart diseases up to 22 million and cancer affects up to 9 million people in America. So NIH estimates that the annual direct health spending on auto immune diagnostics is nearly 100 billion (USD).with 50 million Americans living and copying with auto immune disorders more than 75% of them are women. Autoimmune diseases affect women three times more than men. Some of these diseases have even more higher incidence in women. Autoimmune diseases have been mentioned in the top ten leading causes of the deaths among U.S. women aged 65 and younger. So these diseases represent the fourth largest cause of disability among women in the United States.
In North America, the U.S. and Canada have emerged as the most lucrative markets for autoimmune disease diagnostics. So, both these countries boast sophisticated healthcare infrastructure with advanced laboratory techniques, and increasing awareness about various medical procedures. The overall high healthcare expenditure across the region, puts North America at the front in the global autoimmune disease diagnostics market
Supportive government policies and Increasing public awareness, increasing occurrence of Auto immune disorders, advancements in health care and improved laboratory techniques are the factors driving the growth of the market. The key restraints that hindering the growth of the auto immune diagnostics market are growing rate of diagnostics errors and low occurrence of localized auto immune disorders as compared to systemic diseases.
The North America Auto immune diagnostics Market is broadly categorized based on Test type into Complete Blood Count (CBC), Autoantibody Tests, Antinuclear Antibody Tests, C - reactive protein (CRP), Comprehensive Metabolic panel, Urinalysis, Erythrocyte Sedimentation Rate (ESR) and others.
Based on Disease type the market is categorized into Localized auto immune disease diagnostics and systemic auto immune disease diagnostics. Local auto immune disease diagnostics is further classified into Graves’ disease, Hashimoto's Thyroiditis, Type 1 diabetes, Multiple Sclerosis, Psoriasis and Others. Systemic auto immune disease diagnostics is categorized into Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), and Ankylosing Spondylitis.
Based on End users into Hospitals, Research centers, and diagnostic laboratories and on the basis of geography, the North America Auto immune Diagnostics market is analysed under various regions namely US, and Canada.
Some of the major companies dominating the North America Auto immune disease market by their products and services include Bio-Rad, Siemens Healthcare, Abbott Laboratories, Crescendo Bioscience, Roche Diagnostics SQI Diagnostics, AESKU Diagnostics, INOVA Diagnostics Inc., BioMerieux SA, Beckman Coulter Inc., Hemagen Diagnostics, Quest Diagnostics, Eli lilly, Glaxosmithkline Plc.
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
